SymproicActive Ingredient(s): Naldemedine
FDA Approved: * March 23, 2017
Pharm Company: * SHIONOGI INC
Category: Opioid Dependence
Naldemedine (brand name Symproic in the US and Rizmoic in the European Union) is a medication that is used for the treatment of opioid-induced constipation in adults with chronic non-cancer pain. It is a peripherally acting μ-opioid receptor antagonist and was developed by Shionogi. Clinical studies have found it to possess statistically significant effectiveness for these indications and to be generally well tolerated, with predominantly mild to moderate gastrointesti... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Uses of Symproic pills / New med!
Can Symproic be used for other colon problems besides that which is related to opioid use? I don't take opioids but ...4 REPLIES